Novartis and GSK team in $14.5b IP exchange

23-04-2014

Novartis and GSK team in $14.5b IP exchange

Photo: Rido / Shutterstock.com

Novartis and GSK have agreed to create a consumer healthcare business in a joint venture that involves the exchange of assets worth billions of dollars.


Novartis, GSK, mergers & acquisitions, consumer healthcare

LSIPR